INFORMATION BY CANCER TYPE
Keytruda (pembrolizumab) was granted FDA approval for the treatment of patients with recurrent or advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received two or more lines of chemotherapy and are PD-L1-positive.
Patients with advanced gastric cancer tend to use their health care resources more often and have a worse quality of life than those without the disease
Keytruda (pembrolizumab) showed promising signs of clinical activity for patients with advanced gastric or gastroesophageal junction (GEJ), according to updated findings from KEYNOTE-059 study that were presented at the 2017 American Society for Clinical Oncology (ASCO) Annual Meeting.
Keytruda (pembrolizumab) was granted a priority review to a supplemental biologics license application for the treatment of patients with recurrent or advanced gastric or gastroesophageal junction adenocarcinoma who have undergone at least two courses of chemotherapy.
Dr. Daniel H. Ahn, D.O., spoke with CURE about new advances in gastroesophageal cancers including immunotherapies and stemness inhibitors.
Surgical palliation improved quality of live and solid food intake in patients with certain types of gastric cancer, according to a recent study.
A recent study found that Opdivo improves survival in patients with gastric or gastroesophageal junction (GEJ) cancer.
The JAVELIN trial showed that many patients with gastric cancer could benefit from immunotherapy.
Since chemotherapy can offer only a limited amount of help in fighting gastroesophageal cancers, a growing emphasis on prevention — as well as on the development of immunotherapies — will be extremely important.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Gastric Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of gastric cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Stomach (Gastric) Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing stomach cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Stomach (Gastric) Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for stomach (gastric) cancer.